Abstract
Get full access to this article
View all access options for this article.
References
1.
Personal communication, Norwich-Eaton Pharmaceuticals, September 1980 .
2.
Hailey
FJ
Glascock
HW
Jr
Hewitt
WF
. Pleuropneumonic reactions to nitrofurantoin . N Engl J Med
1969 ; 281 : 1087 –90 .
3.
Kursh
ED
Mostyn
EM
Pershy
L
. Nitrofurantoin pulmonary complications . J Urol
1975 ; 113 : 392 –5 .
4.
Gleckman
R
Alvarez
S
Joybert
DW
. Drug therapy reviews: Nitrofurantoin . Am J Hosp Pharm
1979 ; 36 : 342 –51 .
5.
Simonson
W
Stennett
DJ
Hall
CA
. Nitrofurantoin pneumonitis . Drug Intell Clin Pharm
1977 ; 11 : 654 –6 .
6.
Mitani
GM
. Acute nitrofurantoin pneumonia . Drug Intell Clin Pharm
1974 ; 8 : 16 –19 .
7.
Taskinen
E
Tukiainen
P
Sovijarvi
ARA
. Nitrofurantoin induced alterations in pulmonary tissue . Acta Path Microbiol Scand
1977 ; 85 (sect A): 713 .
8.
Pearsall
HR
Ewalt
J
Tosi
MS
. Nitrofurantoin lung sensitivity: Report of a case with prolonged nitrofurantoin lymphocyte sensitivity and interaction of nitrofurantoin stimulated lymphocytes with alveolar cells . J Lab Clin Med
1974 ; 83 : 728 .